Twist Bioscience Corp [TWST] stock prices are up 1.44% to $54.07 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The TWST shares have gain 17.88% over the last week, with a monthly amount glided 12.79%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Twist Bioscience Corp [NASDAQ: TWST] stock has seen the most recent analyst activity on December 13, 2024, when Wolfe Research initiated its Outperform rating and assigned the stock a price target of $60. Previously, Guggenheim started tracking the stock with Buy rating on June 04, 2024, and set its price target to $53. On January 17, 2024, upgrade upgraded it’s rating to Buy and revised its price target to $45 on the stock. Berenberg started tracking the stock assigning a Buy rating and suggested a price target of $27 on September 27, 2023. Scotiabank initiated its recommendation with a Sector Outperform and recommended $33 as its price target on January 05, 2023. Evercore ISI upgraded its rating to Outperform for this stock on January 03, 2023, and upped its price target to $36.
The stock price of Twist Bioscience Corp [TWST] has been fluctuating between $27.41 and $60.90 over the past year. Currently, Wall Street analysts expect the stock to reach $46 within the next 12 months. Twist Bioscience Corp [NASDAQ: TWST] shares were valued at $54.07 at the most recent close of the market. An investor can expect a potential drop of -14.93% based on the average TWST price forecast.
Analyzing the TWST fundamentals
The Twist Bioscience Corp [NASDAQ:TWST] reported sales of 312.97M for trailing twelve months, representing a surge of 26.53%. Gross Profit Margin for this corporation currently stands at 0.43% with Operating Profit Margin at -0.71%, Pretax Profit Margin comes in at -0.66%, and Net Profit Margin reading is -0.67%. To continue investigating profitability, this company’s Return on Assets is posted at -0.34, Equity is -0.39 and Total Capital is -0.41. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.18.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 52.67 points at the first support level, and at 51.27 for the second support level. However, for the 1st resistance point, the stock is sitting at 55.40, and for the 2nd resistance point, it is at 56.73.
Ratios To Look Out For
It’s worth pointing out that Twist Bioscience Corp [NASDAQ:TWST]’s Current Ratio is 4.88. Further, the Quick Ratio stands at 4.54, while the Cash Ratio is 3.19. Considering the valuation of this stock, the price to sales ratio is 10.29, the price to book ratio is 6.73.
Transactions by insiders
Recent insider trading involved Finn Patrick John, Officer, that happened on Jan 23 ’25 when 2422.0 shares were purchased. Chief Financial Officer, Laponis Adam completed a deal on Jan 10 ’25 to sell 5886.0 shares. Meanwhile, Director CHESS ROBERT sold 5000.0 shares on Jan 07 ’25.
